Loading...
Market
Will a federal investigation into Pfizer's COVID-19 vaccine claims be announced by September 30, 2024?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from federal regulatory bodies (e.g., FDA, DOJ)
Story
Kansas AG Kris Kobach Sues Pfizer Over COVID-19 Vaccine Safety and Effectiveness Claims
Jun 18, 2024, 02:56 AM
The state of Kansas has filed a lawsuit against pharmaceutical giant Pfizer, alleging the company misrepresented the safety and efficacy of its COVID-19 vaccine. Kansas Attorney General Kris Kobach claims that Pfizer made multiple misleading statements about the vaccine, including its safety for pregnant women and the risk of myocarditis. The lawsuit asserts that Pfizer marketed the vaccine as safe despite knowing it was linked to serious adverse events. The state alleges that Pfizer violated the Kansas Consumer Protection Act by hiding risks and making false claims about the vaccine's effectiveness. This legal action is part of a broader scrutiny of COVID-19 vaccine manufacturers.
View original story
Similar markets
Yes • 50%
No • 50%
No significant contamination found • 25%
Contamination confirmed, no recall • 25%
Contamination confirmed, recall issued • 25%
Investigation inconclusive • 25%
Yes • 50%
No • 50%
Clinical hold lifted with no changes • 25%
Clinical hold lifted with additional requirements • 25%
Clinical hold maintained • 25%
Clinical hold converted to full stop • 25%
Warning issued • 25%
Recall issued • 25%
Investigation initiated • 25%
No action taken • 25%
Elements confirmed and deemed unsafe • 25%
Elements confirmed but deemed safe • 25%
Elements not confirmed • 25%
Investigation inconclusive • 25%
Safety concerns resolved • 25%
Further investigation required • 25%
Vaccine trials permanently halted • 25%
Other outcome • 25%
Yes • 50%
No • 50%
No issues found • 25%
Minor issues found • 25%
Moderate issues found • 25%
Severe issues found • 25%
Full recall • 25%
Partial recall • 25%
No recall but warning issued • 25%
No action • 25%
Yes • 50%
No • 50%
